Metropolitan Life Insurance Company (MetLife)’s Claritev Corp CTEV Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CTEV Stock Details CTEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-334	Closed	-$10.8K	–	2193
2024 Q1	$10.8K	Sell	334 -203	-38%	-$8.55K	﹤0.01%	2107
2023 Q4	$30.9K	Hold	537	–	–	﹤0.01%	1705
2023 Q3	$36.1K	Hold	537	–	–	﹤0.01%	1577
2023 Q2	$45.3K	Hold	537	–	–	﹤0.01%	1481
2023 Q1	$22.8K	Sell	537 -41	-7%	-$1.85K	﹤0.01%	1818
2022 Q4	$26.6K	Hold	578	–	–	﹤0.01%	1848
2022 Q3	$66.1K	Hold	578	–	–	﹤0.01%	1274
2022 Q2	$127K	Buy	578 +42	+8%	+$8.3K	0.01%	922
2022 Q1	$100K	Sell	536 -2,018	-79%	-$332K	﹤0.01%	1191
2021 Q4	$453K	Buy	2,554 +993	+64%	+$177K	0.01%	1513
2021 Q3	$352K	Sell	1,561 -1,222	-44%	-$331K	0.01%	1669
2021 Q2	$1.06M	Buy	+2,783	New	+$862K	0.01%	969

Other funds holding CTEV

HFCIV

H&F Corporate Investors VIII San Francisco, California $63.5M AUM 20.79% 1-Year Est. Return

PIF

Public Investment Fund Al Aqiq District, Riyadh, Saudi Arabia $12B AUM 0.61% 1-Year Est. Return

LGP

Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return

Ares Management Los Angeles, California $1.52B AUM 12.97% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CPV Partners Stamford, Connecticut $224M AUM 77.2% 1-Year Est. Return

BPCM

Beach Point Capital Management Santa Monica, California $258M AUM 20.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CTEV Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Claritev Corp (CTEV) in Q2 2024, closing a stake of 334 shares — an estimated $10.8K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CTEV in Q2 2021 and held it in 12 quarters. The position peaked at $1.06M in Q2 2021. 109 funds tracked by Wall St. Rank hold CTEV as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Claritev Corp position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 334 Claritev Corp shares in Q2 2024, an estimated $10.8K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Claritev Corp in Q2 2021 and held it in 12 quarters.
Metropolitan Life Insurance Company (MetLife)'s Claritev Corp position peaked at $1.06M in Q2 2021.
109 funds tracked by Wall St. Rank held Claritev Corp as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.